What is the likely cause and appropriate work‑up and treatment for a 50‑year‑old man with a two‑week history of headache and foul‑smelling sputum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likely Diagnosis: Acute Bacterial Rhinosinusitis with Possible Intracranial Complication

This patient requires urgent CT imaging of the sinuses with contrast to rule out intracranial complications of bacterial sinusitis, given the severe persistent headache lasting 2 weeks combined with foul-smelling sputum suggesting anaerobic infection.

Clinical Reasoning

The combination of persistent headache (2 weeks) and foul-smelling sputum in a 50-year-old male strongly suggests acute bacterial rhinosinusitis (ABRS) with potential complications. The foul-smelling quality is particularly concerning as it indicates:

  • Anaerobic bacterial involvement 1
  • Possible odontogenic source (15% of ABRS cases) 1
  • Risk of intracranial extension given the severe, persistent headache

Red Flags Requiring Immediate Imaging

The 2025 sinusitis guidelines explicitly state that CT imaging with contrast is indicated when complications are suspected based on severe headache 1. Your patient meets this criterion. The guidelines specifically warn that complications include:

  • Orbital involvement
  • Intracranial extension (subdural empyema, brain abscess)
  • Soft tissue involvement

Recent case reports demonstrate that intracranial complications can present with headache as the primary symptom, sometimes without classic meningeal signs 2, 3. One case showed a parafalcine subdural empyema presenting with 2 weeks of headache and fever, initially without obvious meningeal irritation 2.

Immediate Workup Algorithm

1. Urgent Imaging (Do Not Delay)

  • Contrast-enhanced CT of sinuses and brain (iodine contrast) 1
  • Look for: extra-sinus extension, orbital involvement, intracranial abscess, subdural empyema
  • If CT unavailable or equivocal, proceed to gadolinium-enhanced MRI 1

2. Clinical Assessment

  • Check for cranial nerve palsies
  • Assess for proptosis or eye displacement
  • Evaluate for facial swelling
  • Perform thorough neurological exam (even subtle findings like visual field defects or limb drift can indicate intracranial involvement) 2
  • Examine teeth and oral cavity (odontogenic source) 1

3. Laboratory Studies

  • Blood cultures × 2 (if febrile or systemically ill)
  • Complete blood count
  • Consider inflammatory markers (ESR, CRP)

4. Sputum Analysis (if productive cough present)

  • Gram stain looking for mixed flora morphology
  • Anaerobic and aerobic cultures 4
  • The foul smell suggests anaerobes (Fusobacterium, Peptostreptococcus, Bacteroides) 4, 3

Treatment Approach

If Imaging Shows Intracranial Complication:

  • Immediate neurosurgical consultation
  • Broad-spectrum IV antibiotics covering anaerobes and aerobes:
    • Vancomycin + Cefepime + Metronidazole (or Meropenem as alternative) 3
  • Surgical drainage likely required 3
  • Duration: typically 6 weeks IV antibiotics 3

If Imaging Shows Uncomplicated ABRS:

  • High-dose amoxicillin-clavulanate (covers anaerobes and typical pathogens)
  • Consider dental evaluation if odontogenic source suspected 1
  • Symptomatic relief: intranasal steroids, saline irrigation, analgesics 1

Critical Pitfalls to Avoid

  1. Do not dismiss severe persistent headache as "just sinusitis" - this is a red flag for complications 1

  2. Do not delay imaging for "trial of antibiotics first" - intracranial complications require urgent diagnosis and often surgical intervention 2, 3

  3. Do not rely on absence of meningeal signs - subdural empyema and brain abscess can present without classic findings 2

  4. Do not overlook odontogenic source - unilateral foul-smelling drainage strongly suggests dental origin requiring multidisciplinary management 1

  5. Do not use plain films - they are inadequate (76% sensitivity, 79% specificity); CT is the standard 1

Special Considerations for This Patient

The foul-smelling sputum is particularly concerning because:

  • It suggests anaerobic infection which has higher risk of abscess formation 4
  • Recent cases show Fusobacterium necrophorum (an anaerobe) causing brain abscesses from sinusitis in immunocompetent adults 3
  • Anaerobic lung infections classically present with foul-smelling sputum, but post-nasal drainage from sinusitis can mimic this 4

The 2-week duration of severe headache combined with foul-smelling secretions mandates urgent contrast-enhanced imaging to exclude life-threatening intracranial complications before initiating empiric antibiotic therapy.

References

Guideline

clinical practice guideline: adult sinusitis update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Research

Parafalcine empyema, a tricky infectious cause of headache: a case report.

The American journal of emergency medicine, 2015

Research

Anaerobic lung infections.

American family physician, 1994

Related Questions

For a patient with a brain abscess who has been started on cefepime and vancomycin, should the antimicrobial regimen be adjusted?
What are the differential diagnoses for fever and headache in a patient whose symptoms resolve after treatment with paracetamol and ceftriaxone?
How should I initiate semaglutide (GLP‑1 receptor agonist) in an obese patient with type 2 diabetes who is uncontrolled despite basal NPH insulin 30 U twice daily, prandial regular insulin 20 U three times daily, empagliflozin, and linagliptin?
After discontinuing Tolvaptan for 7 days, if the patient's serum sodium returns to 127 mmol/L, should Tolvaptan be restarted?
In the therapeutic management of dermatomyositis, which of the following statements are correct: (a) intravenous immunoglobulin (IVIG) is the first‑line treatment; (b) methotrexate may be administered; (c) corticosteroids are not administered because of the risk of steroid‑induced myopathy; (d) creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) are biochemical markers for monitoring disease activity; (e) hydroxychloroquine is indicated for certain cutaneous manifestations?
After a patient has completed a four‑week course of Tolvaptan 7.5 mg and serum sodium has normalized to 136 mmol/L, should Tolvaptan be restarted or continued?
What levothyroxine dose should be used in a pregnant woman?
What is the thromboembolic (VTE) risk, bleeding risk, and appropriate thromboprophylaxis for a 38‑year‑old ASA II, NYHA I woman with a BMI of 24.5 kg/m² undergoing elective breast augmentation and remodeling, who has normal laboratory values, no history of VTE, is not on estrogen therapy, does not smoke, and is taking levothyroxine and occasional migraine medication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.